User profiles for YOSHIYA TANAKA
 | Yoshiya TanakaProfessor of Internal Medicine, University of Occupational and Environmental Health, Japan Verified email at med.uoeh-u.ac.jp Cited by 58343 |
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
…, R Seror, GH Stummvoll, Y Tanaka… - Arthritis & …, 2019 - Wiley Online Library
Objective To develop new classification criteria for systemic lupus erythematosus ( SLE )
jointly supported by the European League Against Rheumatism ( EULAR ) and the American …
jointly supported by the European League Against Rheumatism ( EULAR ) and the American …
T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ
LYMPHOCYTE migration from blood into tissue depends on integrin-mediated adhesion to
endothelium 1–4 . Adhesion requires not only integrin ligands on the endothelium, but also …
endothelium 1–4 . Adhesion requires not only integrin ligands on the endothelium, but also …
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
…, T Ito, K Notohara, T Sumida, Y Tanaka… - Modern …, 2012 - Taylor & Francis
IgG4-related disease (IgG4-RD) is a novel clinical disease entity characterized by elevated
serum IgG4 concentration and tumefaction or tissue infiltration by IgG4+ plasma cells. …
serum IgG4 concentration and tumefaction or tissue infiltration by IgG4+ plasma cells. …
CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion.
The CD31 (platelet endothelial cell adhesion molecule-1 [PECAM-1]/endothelial cell adhesion
molecule [endoCAM]) molecule expressed on leukocytes, platelets, and endothelial cells …
molecule [endoCAM]) molecule expressed on leukocytes, platelets, and endothelial cells …
[HTML][HTML] Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts
Rheumatoid arthritis (RA) is characterized by a chronic inflammation of the synovial joints
resulting from hyperplasia of synovial fibroblasts and infiltration of lymphocytes, macrophages, …
resulting from hyperplasia of synovial fibroblasts and infiltration of lymphocytes, macrophages, …
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details
…, S Matsui, T Sumida, T Mimori, Y Tanaka… - Modern …, 2012 - Taylor & Francis
IgG4-related disease (IgG4RD) is a novel clinical disease entity characterized by elevated
serum IgG4 concentration and tumefaction or tissue infiltration by IgG4-positive plasma cells. …
serum IgG4 concentration and tumefaction or tissue infiltration by IgG4-positive plasma cells. …
[HTML][HTML] Trial of anifrolumab in active systemic lupus erythematosus
Background Anifrolumab, a human monoclonal antibody to type I interferon receptor subunit
1 investigated for the treatment of systemic lupus erythematosus (SLE), did not have a …
1 investigated for the treatment of systemic lupus erythematosus (SLE), did not have a …
[HTML][HTML] Baricitinib versus placebo or adalimumab in rheumatoid arthritis
Background Baricitinib is an oral, reversible inhibitor of the Janus kinases JAK1 and JAK2 that
may have therapeutic value in patients with rheumatoid arthritis. Methods We conducted a …
may have therapeutic value in patients with rheumatoid arthritis. Methods We conducted a …
Lymphocyte interactions with endothelial cells
Adhesion of lymphocytes to endothelium is vital to lymphocyte migration into lymphoid
tissue and into inflammatory sites. In this review, Yoji Shimizu and colleagues identify the …
tissue and into inflammatory sites. In this review, Yoji Shimizu and colleagues identify the …
Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve‐month data from a twenty‐four–month phase III randomized radiographic …
D Van Der Heijde, Y Tanaka… - Arthritis & …, 2013 - Wiley Online Library
Objective The purpose of this 24‐month phase III study was to examine structural preservation
with tofacitinib in patients with rheumatoid arthritis (RA) with an inadequate response to …
with tofacitinib in patients with rheumatoid arthritis (RA) with an inadequate response to …